Ricci F - Search Results

1

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.

Ricci F, Guffanti F, Damia G, Broggini M. Ricci F, et al. Mol Cancer. 2017 May 30;16(1):97. doi: 10.1186/s12943-017-0662-3. Mol Cancer. 2017. PMID: 28558767 Free PMC article.

2

Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.

Ganzinelli M, Mariani P, Cattaneo D, Fossati R, Fruscio R, Corso S, Ricci F, Broggini M, Damia G. Ganzinelli M, et al. Among authors: ricci f. Eur J Cancer. 2011 May;47(7):1086-94. doi: 10.1016/j.ejca.2010.11.029. Epub 2011 Jan 7. Eur J Cancer. 2011. PMID: 21216588

3

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

Ricci F, Bernasconi S, Perego P, Ganzinelli M, Russo G, Bono F, Mangioni C, Fruscio R, Signorelli M, Broggini M, Damia G. Ricci F, et al. Cell Cycle. 2012 May 15;11(10):1966-76. doi: 10.4161/cc.20308. Epub 2012 May 15. Cell Cycle. 2012. PMID: 22544328

4

Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo.

Carrassa L, Chilà R, Lupi M, Ricci F, Celenza C, Mazzoletti M, Broggini M, Damia G. Carrassa L, et al. Among authors: ricci f. Cell Cycle. 2012 Jul 1;11(13):2507-17. doi: 10.4161/cc.20899. Epub 2012 Jul 1. Cell Cycle. 2012. PMID: 22713237

5

Revisiting ovarian cancer preclinical models: implications for a better management of the disease.

Ricci F, Broggini M, Damia G. Ricci F, et al. Cancer Treat Rev. 2013 Oct;39(6):561-8. doi: 10.1016/j.ctrv.2013.01.005. Epub 2013 Feb 19. Cancer Treat Rev. 2013. PMID: 23434073 Review.

6

ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Ricci F, Bernasconi S, Porcu L, Erba E, Panini N, Fruscio R, Sina F, Torri V, Broggini M, Damia G. Ricci F, et al. Am J Cancer Res. 2013 Apr 3;3(2):221-9. Print 2013. Am J Cancer Res. 2013. PMID: 23593543 Free PMC article.

7

Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model.

Previdi S, Scolari F, Chilà R, Ricci F, Abbadessa G, Broggini M. Previdi S, et al. Among authors: ricci f. PLoS One. 2013 Nov 18;8(11):e79101. doi: 10.1371/journal.pone.0079101. eCollection 2013. PLoS One. 2013. PMID: 24260160 Free PMC article.

8

New class of squalene-based releasable nanoassemblies of paclitaxel, podophyllotoxin, camptothecin and epothilone A.

Borrelli S, Christodoulou MS, Ficarra I, Silvani A, Cappelletti G, Cartelli D, Damia G, Ricci F, Zucchetti M, Dosio F, Passarella D. Borrelli S, et al. Among authors: ricci f. Eur J Med Chem. 2014 Oct 6;85:179-90. doi: 10.1016/j.ejmech.2014.07.035. Epub 2014 Jul 27. Eur J Med Chem. 2014. PMID: 25084144

9

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.

Ricci F, Bizzaro F, Cesca M, Guffanti F, Ganzinelli M, Decio A, Ghilardi C, Perego P, Fruscio R, Buda A, Milani R, Ostano P, Chiorino G, Bani MR, Damia G, Giavazzi R. Ricci F, et al. Cancer Res. 2014 Dec 1;74(23):6980-90. doi: 10.1158/0008-5472.CAN-14-0274. Epub 2014 Oct 10. Cancer Res. 2014. PMID: 25304260

10

Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.

Ricci F, Fratelli M, Guffanti F, Porcu L, Spriano F, Dell'Anna T, Fruscio R, Damia G. Ricci F, et al. Oncotarget. 2017 Jan 31;8(5):7441-7451. doi: 10.18632/oncotarget.7465. Oncotarget. 2017. PMID: 26910918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,420 results

Search Page

Filters